| 000 | 01333 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515022454.0 | ||
| 264 | 0 | _c20060615 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0022-5347 | ||
| 024 | 7 |
_a10.1016/S0022-5347(05)00970-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aInman, Brant A | |
| 245 | 0 | 0 |
_aRe: Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial. _h[electronic resource] |
| 260 |
_bThe Journal of urology _cMay 2006 |
||
| 300 |
_a1960; author reply 1960-1 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Comparative Study; Letter | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 |
_aBCG Vaccine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 773 | 0 |
_tThe Journal of urology _gvol. 175 _gno. 5 _gp. 1960; author reply 1960-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0022-5347(05)00970-5 _zAvailable from publisher's website |
| 999 |
_c16206461 _d16206461 |
||